BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6774996)

  • 1. Pituitary and gonadal desensitization after continuous luteinizing hormone-releasing hormone infusion in normal females.
    Rabin D; McNeil LW
    J Clin Endocrinol Metab; 1980 Oct; 51(4):873-6. PubMed ID: 6774996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
    Lasley BL; Wang CF; Yen SS
    J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in pituitary desensitization and prolongation of gonadotropin release by estrogen during continuous administration of gonadotropin-releasing hormone in women: its antagonism by progesterone.
    Araki S; Chikazawa K; Motoyama M; Ijima K; Abe N; Tamada T
    J Clin Endocrinol Metab; 1985 Mar; 60(3):590-8. PubMed ID: 3919050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of pituitary gonadotropin secretion in postmenopausal females by continuous gonadotropin-releasing hormone administration.
    Heber D; Swerdloff RS
    J Clin Endocrinol Metab; 1981 Feb; 52(2):171-2. PubMed ID: 6780583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle.
    Jewelewicz R; Dyrenfurth I; Ferin M; Bogumil J; Vande Wiele RL
    J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
    Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The response of pituitary gonadotropes to a constant infusion of luteinizing hormone-releasing hormone (LHRH) in normal prepubertal and pubertal children and in children with abnormalities of sexual development.
    Reiter EO; Root AW; Duckett GE
    J Clin Endocrinol Metab; 1976 Aug; 43(2):400-11. PubMed ID: 780368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of gonadotropin-releasing hormone (GnRH) pulse frequency on serum and pituitary concentrations of luteinizing hormone and follicle-stimulating hormone, GnRH receptors, and messenger ribonucleic acid for gonadotropin subunits in cows.
    Vizcarra JA; Wettemann RP; Braden TD; Turzillo AM; Nett TM
    Endocrinology; 1997 Feb; 138(2):594-601. PubMed ID: 9002991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seventy-two hour infusions of LHRH in normal men: gonadotropin and testicular steroid responses.
    McNeil LW; McKenna TJ; Lacroix A; Benveniste R; Rabin D
    J Clin Endocrinol Metab; 1979 Jul; 49(1):149-51. PubMed ID: 156193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
    Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
    J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in plasma luteinizing hormone-releasing hormone and gonadotropin concentrations during constant rate intravenous infusion of luteinizing hormone-releasing hormone in cyclic rats.
    Blake CA
    Endocrinology; 1978 Apr; 102(4):1043-52. PubMed ID: 369828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary content of gonadotropins and receptors for gonadotropin-releasing hormone (GnRH) and hypothalamic content of GnRH during the periovulatory period of the ewe.
    Crowder ME; Nett TM
    Endocrinology; 1984 Jan; 114(1):234-9. PubMed ID: 6317346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol effects on luteinizing hormone releasing hormone-stimulated anterior pituitary and gonadal hormones in women.
    Mendelson JH; Mello NK; Teoh SK; Ellingboe J
    J Pharmacol Exp Ther; 1989 Sep; 250(3):902-9. PubMed ID: 2506337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in rhesus monkeys.
    Stouffer RL; Woodruff TK; Dahl KD; Hess DL; Mather JP; Molskness TA
    J Clin Endocrinol Metab; 1993 Jul; 77(1):241-8. PubMed ID: 8325947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary and ovarian response to acute stimulation with LH-RH in normal and anovulatory women.
    Aparicio NJ; Casas PR; Galimberti DM; de Laborde NP; Badano A; GarcĂ­a EP; Meichi HR; Mirkin A; Szejner M; Jaitt A; Margulies M; Rosner JM
    Int J Fertil; 1977; 22(1):6-15. PubMed ID: 18416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rhesus monkey corpus luteum is dependent on pituitary gonadotropin secretion throughout the luteal phase of the menstrual cycle.
    Hutchison JS; Zeleznik AJ
    Endocrinology; 1984 Nov; 115(5):1780-6. PubMed ID: 6436009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent long-term administration of a potent gonadotropin-releasing hormone agonist in normal men.
    Doelle G; Linde R; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D
    Int J Fertil; 1982; 27(4):234-7. PubMed ID: 6131043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The two pools of pituitary gonadotropin: regulation during the menstrual cycle.
    Hoff JD; Lasley BL; Wang CF; Yen SS
    J Clin Endocrinol Metab; 1977 Feb; 44(2):302-12. PubMed ID: 320220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
    Lemay A; Faure N
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of follicular phase pituitary-gonadal function by a potent new gonadotropin-releasing hormone antagonist with reduced histamine-releasing properties (ganirelix).
    Nelson LR; Fujimoto VY; Jaffe RB; Monroe SE
    Fertil Steril; 1995 May; 63(5):963-9. PubMed ID: 7536693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.